BOSTON SCIENTIFIC TO COLLABORATE WITH AFFINERGY ON NOVEL CARDIOVASCULAR STENT COATINGS

Affinergy, a Duke University spinout with a proprietary site-specific biological delivery system, recently signed a collaboration agreement with Boston Scientific to investigate new coatings for cardiovascular stents. Boston Scientific is a worldwide developer, manufacturer, and marketer of medical devices whose products are used in a broad range of interventional medical specialties.

Yahoo News (http://biz.yahoo.com/bw/051101/15669.html?.v=1)